These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 28525376)

  • 1. Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
    Wangpaichitr M; Wu C; Li YY; Nguyen DJM; Kandemir H; Shah S; Chen S; Feun LG; Prince JS; Kuo MT; Savaraj N
    Oncotarget; 2017 Jul; 8(30):49275-49292. PubMed ID: 28525376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
    Ai Z; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration.
    Wangpaichitr M; Theodoropoulos G; Nguyen DJM; Wu C; Spector SA; Feun LG; Savaraj N
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
    Seol HS; Lee SE; Song JS; Lee HY; Park S; Kim I; Singh SR; Chang S; Jang SJ
    Cancer Lett; 2016 Nov; 382(2):157-165. PubMed ID: 27612558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells.
    Wangpaichitr M; Sullivan EJ; Theodoropoulos G; Wu C; You M; Feun LG; Lampidis TJ; Kuo MT; Savaraj N
    Mol Cancer Ther; 2012 Mar; 11(3):604-15. PubMed ID: 22248473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
    Fortunato A
    Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
    Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
    Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer.
    Nguyen DJM; Theodoropoulos G; Li YY; Wu C; Sha W; Feun LG; Lampidis TJ; Savaraj N; Wangpaichitr M
    Mol Cancer Res; 2020 Jan; 18(1):105-117. PubMed ID: 31628200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
    Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
    Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
    Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M
    J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase A in nerve cells confers resistance to amyloid β and other toxins by decreasing mitochondrial respiration and reactive oxygen species production.
    Newington JT; Rappon T; Albers S; Wong DY; Rylett RJ; Cumming RC
    J Biol Chem; 2012 Oct; 287(44):37245-58. PubMed ID: 22948140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondrial carrier SLC25A10 regulates cancer cell growth.
    Zhou X; Paredes JA; Krishnan S; Curbo S; Karlsson A
    Oncotarget; 2015 Apr; 6(11):9271-83. PubMed ID: 25797253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cisplatin-resistant human tumor cells with metabolic inhibitors.
    Sullivan EJ; Kurtoglu M; Brenneman R; Liu H; Lampidis TJ
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):417-27. PubMed ID: 24352250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer.
    Lu H; Tong W; Jiang M; Liu H; Meng C; Wang K; Mu X
    ACS Nano; 2024 Aug; 18(32):21156-21170. PubMed ID: 39088743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Integrated Stress Response Induced by Salubrinal Promotes Cisplatin Resistance in Human Gastric Cancer Cells via Enhanced xCT Expression and Glutathione Biosynthesis.
    Wang SF; Wung CH; Chen MS; Chen CF; Yin PH; Yeh TS; Chang YL; Chou YC; Hung HH; Lee HC
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes.
    Manerba M; Di Ianni L; Fiume L; Roberti M; Recanatini M; Di Stefano G
    Eur J Pharm Sci; 2015 Jul; 74():95-102. PubMed ID: 25930121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin resistance in human cervical, ovarian and lung cancer cells.
    Chen J; Solomides C; Parekh H; Simpkins F; Simpkins H
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1217-27. PubMed ID: 25894720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole-triggered GSH synthesis via activation of glutamate transporters to antagonize methylmercury-induced oxidative stress in rat cerebral cortex.
    Deng Y; Xu ZF; Liu W; Xu B; Yang HB; Wei YG
    Oxid Med Cell Longev; 2012; 2012():534705. PubMed ID: 22966415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.